<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>CONTEXT: Mast cells may be increased as a reactive <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> in various <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> and malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, as well as in <z:e sem="disease" ids="C0221013" disease_type="Disease or Syndrome" abbrv="">systemic mast cell disease</z:e> (SMCD) </plain></SENT>
<SENT sid="1" pm="."><plain>There are no statistical differences in mast cell numbers in reactive <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> and SMCD; however, SMCD usually reveals dyspoietic mast cells and other dyspoietic bone marrow elements </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, SMCD is frequently (45%) associated with <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e>) (17%) and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (MDSs) (28%) </plain></SENT>
<SENT sid="3" pm="."><plain>Thus, it has been suggested that SMCD may represent one aspect of a <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorder</z:e> that involves multiple bone marrow lineages </plain></SENT>
<SENT sid="4" pm="."><plain>OBJECTIVE: To perform a systematic evaluation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e> and MDSs without SMCD for dyspoietic mast cells </plain></SENT>
<SENT sid="5" pm="."><plain>DESIGN: A total of 55 MPDs or MDSs were reviewed, including 20 cytogenetically proven <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemias</z:hpo>, 6 essential <z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">thrombocythemias</z:e>, 2 <z:hpo ids='HP_0001901'>polycythemia</z:hpo> veras, 21 cytogenetically proven MDSs, and 6 <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Cases of idiopathic <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> were not included due to lack of spicules </plain></SENT>
<SENT sid="7" pm="."><plain>The bone marrow aspirates were reviewed for an increase in mast cells (1+ to 3+), dyspoietic features within mast cells (decreased cytoplasmic granularity, uneven granule distribution), and a predominance of fusiform mast cells </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: <z:hpo ids='HP_0000001'>All</z:hpo> cases, except 2 MDSs, had evaluable bone marrow spicules </plain></SENT>
<SENT sid="9" pm="."><plain>Of interest, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e> were significantly more associated with increased and dyspoietic mast cells (57% and 61%, respectively) than were the MDSs (11% and 4%, respectively) </plain></SENT>
<SENT sid="10" pm="."><plain>The 2 <z:hpo ids='HP_0001901'>polycythemia</z:hpo> veras and 6 <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo> did not reveal increased or dyspoietic mast cells </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: These findings indicate that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e> (<z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e>) frequently contain neoplastic mast cells as the spectrum of abnormal bone marrow cells </plain></SENT>
<SENT sid="12" pm="."><plain>This feature, in conjunction with other parameters, may possibly be useful in the differential diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e> and MDSs </plain></SENT>
<SENT sid="13" pm="."><plain>Our findings, compared with the previously reported findings in SMCD, suggest that SMCD may be more closely related to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPDs</z:e> than to MDSs </plain></SENT>
</text></document>